Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine vs Paroxetine in MDD
NCT00463242Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of agomelatine in major depressive disorder (MDD), sponsored by Novartis. Started Mar 2007; status: completed.
02
Drugs
agomelatine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00463242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463242.